Found 7 matching trials
A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Cancer PHASE2 This is a Phase II, open-label, non-randomized study in patients with local...
Show More Learn More & Join Trial
Study of NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Pancreatic Cancer PHASE2 This study will compare two different regimens for patients with BRCA1/2 or...
Show More Status
Active Not Recruiting
Location
Princess Margaret Cancer Centre
Learn More & Join Trial
A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast Cancer PHASE2 This is a Phase II, open-label, non-randomized study in patients with local...
Show More Learn More & Join Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor AZD1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery PHASE1 This partially randomized phase I/II trial studies the side effects and bes...
Show More Location
Northwestern University
Learn More & Join Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery PHASE2 RATIONALE: Drugs used in chemotherapy, such as paclitaxel albumin-stabilize...
Show More Location
Ohio State University Comprehensive Cancer Center
Learn More & Join Trial
ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast Cancer PHASE2 RATIONALE: Drugs used in chemotherapy, such as ABI-007(Nab-Paclitaxel((Nano...
Show More Location
Mobile Infirmary Medical Center
Learn More & Join Trial
Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of Esophagus PHASE2 Albumin-bound paclitaxel regimen in advanced NSCLC has a better tumor respo...
Show More Location
The first affiliated hospital, Zhejiang University
Learn More & Join Trial